Revive Therapeutics Ltd.Revive Therapeutics Ltd.Revive Therapeutics Ltd.

Revive Therapeutics Ltd.

No trades
See on Supercharts
Next report date
Report period
EPS estimate
Revenue estimate
Market capitalization
‪3.02 M‬USD
−0.0104USD
‪−4.11 M‬USD
0.00USD
‪410.55 M‬
Beta (1Y)
3.27

About REVIVE THERAPEUTICS LTD.


CEO
Michael Frank
Headquarters
Toronto
Founded
2012
FIGI
BBG00BH5YFB2
Revive Therapeutics Ltd. engages in the research, development, and commercialization of drugs for disorders and infectious diseases. The company was founded by Fabio Chianelli on March 27, 2012 and is headquartered in Toronto, Canada.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬

See all ideas 

Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.

Frequently Asked Questions


The current price of RVVTF is 0.0065 USD — it has decreased by −4.41% in the past 24 hours. Watch Revive Therapeutics Ltd. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on OTC exchange Revive Therapeutics Ltd. stocks are traded under the ticker RVVTF.
RVVTF stock has risen by 0.62% compared to the previous week, the last month showed zero change in price, over the last year Revive Therapeutics Ltd. has showed a −74.00% decrease.
RVVTF reached its all-time high on Dec 14, 2020 with the price of 0.7200 USD, and its all-time low was 0.0055 USD and was reached on Oct 22, 2024. View more price dynamics on RVVTF chart.
See other stocks reaching their highest and lowest prices.
RVVTF stock is 11.60% volatile and has beta coefficient of 3.27. Track Revive Therapeutics Ltd. stock price on the chart and check out the list of the most volatile stocks — is Revive Therapeutics Ltd. there?
Today Revive Therapeutics Ltd. has the market capitalization of ‪3.02 M‬, it has increased by 99.23% over the last week.
Yes, you can track Revive Therapeutics Ltd. financials in yearly and quarterly reports right on TradingView.
Revive Therapeutics Ltd. is going to release the next earnings report on Nov 28, 2024. Keep track of upcoming events with our Earnings Calendar.
RVVTF net income for the last quarter is ‪−1.89 M‬ USD, while the quarter before that showed ‪−1.38 M‬ USD of net income which accounts for −36.71% change. Track more Revive Therapeutics Ltd. financial stats to get the full picture.
No, RVVTF doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, RVVTF shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Revive Therapeutics Ltd. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Revive Therapeutics Ltd. technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Revive Therapeutics Ltd. stock shows the sell signal. See more of Revive Therapeutics Ltd. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.